These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 16043013)

  • 21. [Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer].
    Oztürk T; Karadibak K; Catal D; Cakan A; Tugsavul F; Cirak K
    Agri; 2008 Jul; 20(3):20-5. PubMed ID: 19085178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.
    Portenoy RK; Taylor D; Messina J; Tremmel L
    Clin J Pain; 2006; 22(9):805-11. PubMed ID: 17057563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment efficacy of neural blockade in specialized palliative care services in Japan: a multicenter audit survey.
    Tei Y; Morita T; Nakaho T; Takigawa C; Higuchi A; Suga A; Tajima T; Ikenaga M; Higuchi H; Shimoyama N; Fujimoto M
    J Pain Symptom Manage; 2008 Nov; 36(5):461-7. PubMed ID: 18504097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report].
    Shinjo T; Okada M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1997-2000. PubMed ID: 16282744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The adverse effects of morphine: a prospective survey of common symptoms during repeated dosing for chronic cancer pain.
    Glare P; Walsh D; Sheehan D
    Am J Hosp Palliat Care; 2006; 23(3):229-35. PubMed ID: 17060284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain.
    Lasheen W; Walsh D; Mahmoud F; Sarhill N; Rivera N; Davis M; Lagman R; Legrand S
    Palliat Med; 2010 Jan; 24(1):9-16. PubMed ID: 19910396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE; Klaschik E
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty.
    Patanwala AE; Jarzyna DL; Miller MD; Erstad BL
    Pharmacotherapy; 2008 Dec; 28(12):1453-60. PubMed ID: 19025426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Usefulness of fentanyl patch (Durotep) in cancer patients when rotated from morphine preparations].
    Akiyama Y; Iseki M; Izawa R; Ishii K; Miyazaki T; Yamaguchi S; Tani Y
    Masui; 2007 Mar; 56(3):317-23. PubMed ID: 17366919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of the fentanyl iontophoretic transdermal system (ITS) and intravenous patient-controlled analgesia (IV PCA) with morphine for pain management following abdominal or pelvic surgery.
    Minkowitz HS; Rathmell JP; Vallow S; Gargiulo K; Damaraju CV; Hewitt DJ
    Pain Med; 2007; 8(8):657-68. PubMed ID: 18028044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine].
    Binhas M; Krakowski I; Marty J
    Ann Fr Anesth Reanim; 2007 Jun; 26(6):502-15. PubMed ID: 17560755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
    Otis J; Rothman M
    Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department.
    Borland M; Jacobs I; King B; O'Brien D
    Ann Emerg Med; 2007 Mar; 49(3):335-40. PubMed ID: 17067720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer-related pain.
    Lorvidhaya V; Katanyoo K; Srisomboon J; Suprapaphorn P; Cheewakriangkrai C
    J Med Assoc Thai; 2004 Mar; 87(3):319-25. PubMed ID: 15117050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Home palliative care--2 case reports: a long-term cancer pain management with transdermal fentanyl].
    Fujimoto M; Sakuyama T; Mizutani Y; Kuroda T; Yanaga K
    Gan To Kagaku Ryoho; 2004 Dec; 31 Suppl 2():190-3. PubMed ID: 15645768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.